Sanofi India Ltd
₹4040.70
(0.76%)
Sat, 28 Feb 2026, 10:42 pm
Health Technology
Pharmaceuticals: Major
24.5KSanofi India Return on Equity (ROE) History
| Particulars | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 26.28 | 18.39 | 18.55 | 13.21 | 24.80 | 28.96 | 27.95 | 29.86 | 26.53 | 42 | 42.23 | 32.53 | 33.31 | 38.44 | 39.01 | 40.11 | 19.25 | 21.71 | 30.82 | 34.11 |
| Price to book ratio | 7.28 | 5.12 | 3.79 | 2.65 | 4.19 | 4.43 | 4.79 | 4.38 | 4.72 | 5.57 | 6.17 | 5.26 | 5.36 | 6.59 | 6.62 | 9.04 | 8.17 | 10.56 | 18.30 | 16.38 |
| Price to sales ratio | 4.72 | 3.52 | 3.07 | 2.23 | 4.01 | 3.95 | 4.14 | 3.37 | 3.54 | 4.22 | 4.62 | 4.23 | 4.45 | 5.34 | 5.32 | 6.62 | 6.17 | 4.87 | 9.32 | 7.02 |
| Price to cash flow ratio | 22.65 | 20.33 | 20.69 | 13.91 | 22.44 | 26.58 | 20.35 | 16.77 | 20.85 | 26.33 | 39.33 | 25.99 | 21.59 | 32.31 | 32.10 | 27.86 | 29.31 | 29.55 | 66.86 | 29.49 |
| Enterprise value | 35.19B | 27.27B | 22.88B | 16.98B | 33.18B | 38.35B | 51.1B | 48.47B | 60.98B | 78.07B | 94.66B | 93.35B | 101.28B | 137.99B | 150.28B | 179.71B | 166.52B | 124.79B | 181.92B | 138.21B |
| Enterprise value to EBITDA ratio | 16.11 | 12.41 | 13.62 | 10.06 | 21.13 | 19.42 | 21.64 | 16.01 | 15.53 | 23.79 | 21.34 | 18.05 | 19.22 | 22.72 | 23.19 | 25 | 21.74 | 17.38 | 36.25 | 27.58 |
| Debt to equity ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.01 | 0.01 | 0.02 | 0.02 | 0.02 |
| Return on equity % | 29.68 | 29.91 | 21.96 | 21.64 | 17.88 | 15.93 | 17.95 | 15.22 | 18.80 | 13.91 | 15.27 | 17.33 | 16.68 | 17.93 | 17.77 | 20.94 | 43.47 | 35.45 | 31.83 | 33.45 |
Sanofi India Ltd Return on Equity
The Sanofi India Ltd Return on Equity is a key financial metric used by investors to evaluate Sanofi India Ltd's valuation, profitability, and overall financial performance. Tracking the Sanofi India Ltd Return on Equity helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Sanofi India Ltd (NSE: SANOFI, BSE: 500674) is currently trading at ₹4040.70, with a market capitalization of ₹92.73B. As a leading company in the Health technology sector and Pharmaceuticals: major industry, monitoring the Sanofi India Ltd Return on Equity is essential for fundamental analysis.
Sanofi India Ltd Return on Equity Current Value
The current Sanofi India Ltd Return on Equity stands at 33.45.
The latest Sanofi India Ltd Return on Equity has increased compared to the previous period, indicating rising valuation or improved investor sentiment.
Sanofi India Ltd Return on Equity Historical Trend
The Sanofi India Ltd Return on Equity has shown the following historical trend:
- 2024: 33.45
- 2023: 31.83
- 2022: 35.45
- 2021: 43.47
- 2020: 20.94
The recent rise in Sanofi India Ltd Return on Equity suggests strengthening valuation trends and improving market sentiment.
What Sanofi India Ltd Return on Equity Indicates for Investors
The Sanofi India Ltd Return on Equity plays a crucial role in understanding the company's financial health and valuation.
ROE indicates how efficiently the company generates returns for shareholders.
Sanofi India Ltd Return on Equity Analysis Summary
The Sanofi India Ltd Return on Equity remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Sanofi India Ltd Return on Equity should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Sanofi India Ltd Return on Equity helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800